Evidence map›Paper›PMID 28733363›Full record

ArticleDisease models & mechanisms2017

Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.

Mostafa Kiamehr, Leena E Viiri, Terhi Vihervaara, Kaisa M Koistinen, Mika Hilvo, Kim Ekroos, Reijo Käkelä, Katriina Aalto-Setälä

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. AnJournal of biological methods · 2020
    Article
  10. Lipid Mediated Regulation of Adult Stem Cell Behavior.Frontiers in cell and developmental biology · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mostafa KiamehrFaculty of Medicine and Life Sciences, University of Tampere, Tampere, 33520, Finland mostafa.kiamehr@uta.fi.ORCID 0000-0003-1894-3237
Leena E ViiriFaculty of Medicine and Life Sciences, University of Tampere, Tampere, 33520, Finland.
Terhi VihervaaraZora Biosciences, Espoo, 02150, Finland.
Kaisa M KoistinenZora Biosciences, Espoo, 02150, Finland.
Mika HilvoZora Biosciences, Espoo, 02150, Finland.
Kim EkroosZora Biosciences, Espoo, 02150, Finland.
Reijo KäkeläDepartment of Biosciences, University of Helsinki, Helsinki, 00014, Finland.
Katriina Aalto-SetäläFaculty of Medicine and Life Sciences, University of Tampere, Tampere, 33520, Finland.
Zora Biosciences (Finland) · FITampere University · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocyte-like cells (HLCs) differentiated from human induced pluripotent stem cells (iPSCs) offer an alternative model to primary human hepatocytes to study lipid aberrations. However, the detailed lipid profile of HLCs is yet unknown. In the current study, functional HLCs were differentiated from iPSCs generated from dermal fibroblasts of three individuals by a three-step protocol through the definitive endoderm (DE) stage. In parallel, detailed lipidomic analyses as well as gene expression profiling of a set of lipid-metabolism-related genes were performed during the entire differentiation process from iPSCs to HLCs. Additionally, fatty acid (FA) composition of the cell culture media at different stages was determined. Our results show that major alterations in the molecular species of lipids occurring during DE and early hepatic differentiation stages mainly mirror the quality and quantity of the FAs supplied in culture medium at each stage. Polyunsaturated phospholipids and sphingolipids with a very long FA were produced in the cells at a later stage of differentiation. This work uncovers the previously unknown lipid composition of iPSC-HLCs and its alterations during the differentiation in conjunction with the expression of key lipid-associated genes. Together with biochemical, functional and gene expression measurements, the lipidomic analyses allowed us to improve our understanding of the concerted influence of the exogenous metabolite supply and cellular biosynthesis essential for iPSC-HLC differentiation and function. Importantly, the study describes in detail a cell model that can be applied in exploring, for example, the lipid metabolism involved in the development of fatty liver disease or atherosclerosis.

Indexed as

Lipid MetabolismAnimalsCell DifferentiationCell LineCholesterol EstersEndodermFatty Acids, UnsaturatedGene Expression RegulationHepatocytesHumansInduced Pluripotent Stem CellsMetabolomicsMicePhosphatidylcholinesSphingolipidsCholesterol EstersFatty Acids, UnsaturatedPhosphatidylcholinesSphingolipidsCell modelDifferentiationFatty acidHepatocyte-like cellHLCInduced pluripotent stem celliPSCLipidomics

Identifiers

PMID28733363
PMCPMC5611970
OpenAlexW2737677209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.